概要
As a direct and sole result of the outbreak of the coronavirus disease (COVID-19) and due to circumstances beyond our control, DIA announces that it has decided to change the format of the upcoming DIA CoRE Singapore Annual Meeting from “face-to-face” (in-person) to entirely virtual.
For more information, please review the list of Frequently Asked Questions.
Organized by DIA and CoRE
In the current landscape of rapid advances in medical sciences and technology, many opportunities abound for improving the quality and delivery of healthcare. New technology, systems and concepts are constantly explored to bring better health outcomes for patients.
Beyond innovations in health products, IT continue to advance the changes with increasing utility of data sciences and Artificial Intelligence in transforming healthcare management. Given the complex interactions among the stakeholders, it is vital to be well-informed of the significant progresses and collaboration with relevant stakeholders to fully harness the value of this exciting evolution in healthcare.
Download the Preliminary Agenda to Explore Discussions on:- eLabeling as a Tool for Enhancing Patient Care
- Disruptive Technology - Innovating Clinical Trials
- Personalized Healthcare - Pivotal Role for Next Generation Sequencing
- 3D Printing for Personalized Medical Devices
- Relating Medical Device and Pharmaceutical Regulations
- Inclusivity - The Importance of the Patient Perspective
Featured
Want to learn more about DIA-CoRE Singapore Annual Meeting 2020? You've come to the right site!
プログラム委員会
-
Dorothee Grimald, PharmD Director, Global Regulatory Policy
Merck Sharp & Dohme (MSD), Germany -
James Leong, PhD, MPharm Head,Health Products & Regulatory Science Centre of Regulatory Excellence (CoRE)
Duke NUS Medical School, Singapore -
Audrey Ooi, MSc Head- Business Development
Clinical Research Malaysia, Malaysia -
Finny Liu, MSc, RPh APAC Regional Regulatory Policy Lead
Roche, Singapore -
Jack Wong Founder
ARPA (Asia Regulatory Professionals Association) , Singapore -
Mei Ding JAPAC Regional Lead, Policy & Intelligence
Abbvie Pte. Ltd., Singapore -
Thean Soo Lo
Regulatory Affairs Management Consultant, Singapore -
Yasha Huang Head of Regulatory Policy Asia Pacific, Global Regulatory Policy & Intelligence
Roche Diagnostics, Singapore -
Shun Jin, MBA Head, Regulatory Affairs, APMA
Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore -
Fredrik Nyberg Managing Director, Asia Pacific
MedTech Innovator, Singapore -
Jing Ping Yeo, PhD Head - Transformation
George Clinical, Singapore -
Kum Cheun Wong, PharmD Head Asia Pacific Regulatory & Development Policy
Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore -
Fengyun(Vicky) Han Senior Director, Head of Regulatory Policy for Asia Pacific
Johnson & Johnson Pte. Ltd., Singapore